Andheri East, Mumbai, Maharashtra
50 Piece (MOQ)
Business Type | Exporter, Trader |
Composition | Rituximab |
Indication | Blood Cancer, Rheumatoid Arthritis and Non-Hodgkin’s Lymphoma |
Dose/Strength | 500mg |
Click to view more |
Preferred Buyer From
Location | Worldwide |
Product Details
At present, Rituximab is the most important mAb of clinical value in patients with Bcell lymphoid malignancies. RituxiRel is currently approved in two indications: Non- Hodgkin's Lymphoma (NHL), blood cancer and Rheumatoid Arthritis (RA).
Hi! Simply click below and type your query.
Our experts will reply you very soon.